NCT04354545 Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications
| NCT ID | NCT04354545 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Los Angeles |
| Condition | Glaucoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 75 participants |
| Start Date | 2021-04-01 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 75 participants in total. It began in 2021-04-01 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To evaluate glaucoma patients' response to treatment with Xiidra, an FDA-approved drug for ocular surface discomfort, which will be prescribed as standard of care treatment.
Eligibility Criteria
Inclusion Criteria: * Currently using one or more topical glaucoma antihypertensives * Self-described symptoms of ocular surface discomfort * Xiidra is being prescribed as part of the subject's standard care Exclusion Criteria: * History of glaucoma filtration surgery, history of ocular surface surgery (pterygium, conjunctivoplasty, etc.), * current use of topical cyclosporine * current use of topical steroids * incisional ocular surgery within 6 months
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04354545 clinical trial?
This trial is open to participants of all sexes, studying Glaucoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04354545 currently recruiting?
Yes, NCT04354545 is actively recruiting participants. Contact the research team at BBert@mednet.ucla.edu for enrollment information.
Where is the NCT04354545 trial being conducted?
This trial is being conducted at Fountain Valley, United States.
Who is sponsoring the NCT04354545 clinical trial?
NCT04354545 is sponsored by University of California, Los Angeles. The trial plans to enroll 75 participants.